Zobrazeno 1 - 4
of 4
pro vyhledávání: '"J. D. Edison"'
Autor:
S. M. Gordon, J. B. Hughes, R. Nee, R. S. Stitt, W. T. Bailey, D. J. Little, J. D. Edison, S. W. Olson
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-7 (2019)
Abstract Background Scleroderma Renal Crisis (SRC) is associated with significant morbidity and mortality. While prednisone is strongly associated with SRC, there are no previous large cohort studies that have evaluated ace inhibitor (ACEi) calcium c
Externí odkaz:
https://doaj.org/article/5ed77cb28b3e4c59831f9ba2a62fb862
Autor:
S. W. Olson, J. J. Lee, M. Poirier, D. J. Little, L. K. Prince, T. P. Baker, J. D. Edison, K. C. Abbott
Publikováno v:
Autoimmune Diseases, Vol 2017 (2017)
Background. The subclinical pathophysiology of proliferative lupus nephritis (PLN) has not been fully elucidated. Myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA) is associated with PLN, but prediagnostic levels have not been reported.
Externí odkaz:
https://doaj.org/article/4cfe573239e3407dacaf4b7373e6add0
Autor:
J D Edison, William R. Gilliland
Publikováno v:
Clinical Pharmacology & Therapeutics. 91:561-566
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0d46bc9d0b5d10bf052ceaf794a2265
https://doi.org/10.1038/clpt.2012.8
https://doi.org/10.1038/clpt.2012.8
Publikováno v:
Clinical pharmacology and therapeutics. 92(4)
Treatment of rheumatoid arthritis (RA) has advanced significantly over the past decade, in part because of the identification of key elements in the immunopathogenesis of the disease, leading to the development of targeted immune-based therapies. Des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80cfbb07f56cc9cf5b97c3bacf9d383d
https://pubmed.ncbi.nlm.nih.gov/22910444
https://pubmed.ncbi.nlm.nih.gov/22910444